Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain



Roots Analysis has announced the addition of “Digital Twins Market, 2022-2035” report to its list of offerings.



Since the first application of the digital twin concept for manufacturing in 2002, it… Continue

Over the past 50 years, the medical device industry has seen several notable developments. In fact, the use of biomedical devices, such as medical implants, surgical instruments, and prostheses has increased substantially over the time.



Cardioverter defibrillators, prosthetic hips and knees, contact lenses, and cardiac pacemakers are some of the most commonly implanted medical devices, while fixation devices and artificial joints account for about 44% of all medical devices. Despite… Continue

Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly opting for innovative technologies and software solutions for conducting clinical trials



Roots Analysis has announced the addition of “Clinical Trials Software Market, 2022-2035” report to its list of offerings.



Excessive capital expenditure and other complexities associated with the traditional clinical trials has imposed… Continue

Driven by the development of advanced methods for preparation and characterization of liposomes, and the application of these molecules in therapeutics and diagnostics, the demand for liposomes is expected to rise in the coming years.



London



Roots Analysis has announced the addition of “Liposome Manufacturing Market, 2022-2035” report to its list of offerings.



Despite the growing interest in liposome-based therapeutics and diagnostics, the development and… Continue

The in-house development of peptide API requires necessary expertise and capabilities, including design, construction and maintenance of a facility which demands significant capital investments. Therefore, several small drug developers and, at times, certain pharma giants as well, have started outsourcing their manufacturing operations to contract service providers.



Over the years, the popularity of biologics has led to an evident shift in the focus of pharmaceutical companies, from… Continue

Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems.



Roots Analysis has announced the addition of “Single-use Upstream Bioprocessing Market, 2022-2035” report to its list of offerings.



The report features an extensive study on the extensive study of the current landscape and the likely future… Continue

Growing interest for combination products, coupled with the ongoing challenges of combining drug / biologic with a medical device, is anticipated to drive the demand for outsourcing combination products development and testing.



Roots Analysis has announced the addition of “Combination Product Services Market, 2022-2035” report to its list of offerings.



The development of drug-device combination products is a long-drawn-out process that not only requires novel technologies… Continue

Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases



London

Roots Analysis has announced the addition of the “Rare Kidney Disorders Market, 2022–2035” report to its list of offerings.



More than 90 candidates targeting rare kidney disorders are currently… Continue

In recent years, the use of biosensors in drug discovery has been on the rise, driven by several technological advancements and the growing demand for inexpensive and effective techniques for analyzing potential drug candidates.



Roots Analysis has announced the addition of “Biosensors Market: Focus on Drug Discovery and Drug Development, 2022 - 2035” report to its list of offerings.



A number of drug developers are already using novel biosensors for various drug discovery… Continue

Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes.



London

Roots Analysis has announced the addition of the “At home testing Kits Market , 2022–2035” report to its list of offerings.

Owing to several advantages offered by at-home self-testing kits for diagnostics… Continue

Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug.



Bioavailability refers to the proportion of a drug that reaches systemic circulation unaltered, post dose administration. Additionally, it is a direct consequence of the absorption potential of an active pharmaceutical ingredient (API). The bioavailability of a drug is… Continue

SARM1 inhibitors, having demonstrated the ability to prevent axonal degeneration, are being evaluated for the treatment of a number of neurodegenerative disorders. Once approved, these therapies are likely to capture a significant market share



Roots Analysis has announced the addition of “SARM1 Inhibitors Therapeutics Market , 2022 – 2040” report to its list of offerings.



Presently, several industry and non-industry stakeholders are evaluating SARM1 inhibitors as potential… Continue

Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years.



Roots Analysis has announced the addition of Cell and Gene Therapy CRO Market , 2022-2035” report to its list of offerings.



In order to mitigate the challenges associated with the cell and gene therapies research and development, around… Continue

Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic disorders and other disorders.



mRNA therapeutics and vaccines have emerged as a promising alternative to conventional treatment approaches. During our research, we were able to identify more than… Continue

The success of currently employed artificial intelligence (AI) solutions has encouraged researchers to explore the potential of such technologies in the healthcare sector, with its prime focus being oncology, to enable the treatment of several prevalent malignancies.



London



Roots Analysis has announced the addition of “Artificial Intelligence in Oncology Market, 2022-2035” report to its list of offerings.



Several AI technologies demonstrating the potential to… Continue